VIS
MRNA icon

Vega Investment Solutions’s Moderna MRNA Stock Holding History

Vega Investment Solutions’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335K Sell
6,594
-211
-3% -$9.84K 0.08% 66
2025
Q4 		$201K Buy
+6,805
New +$185K 0.03% 79
2025
Q2 		$105K Sell
3,822
-258
-6% -$6.79K 0.02% 73
2025
Q1 		$116K Buy
4,080
+3,000
+278% +$106K 0.02% 102
2024
Q4 		$44.9K Buy
+1,080
New +$51.6K 0.04% 65

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vega Investment Solutions's MRNA Position: Q1 2026 in Review

Vega Investment Solutions reduced its Moderna (MRNA) stake by 3.1% in Q1 2026, selling an estimated $9.84K and leaving 6,594 shares worth $335K. The position accounts for 0.08% of the portfolio, ranked #66.

Vega Investment Solutions first reported a position in MRNA in Q4 2024 and has held it in 5 quarters since. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Vega Investment Solutions held 6,594 shares of Moderna worth $335K as of Q1 2026.
  • Vega Investment Solutions sold 211 Moderna shares in Q1 2026, an estimated $9.84K.
  • Moderna made up 0.08% of Vega Investment Solutions's portfolio in Q1 2026, its #66 holding.
  • Vega Investment Solutions first reported a position in Moderna in Q4 2024 and has held it in 5 quarters since.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Vega Investment Solutions's 13F filing for Q1 2026, filed 14 May 2026.